BI Asset Management Fondsmaeglerselskab A S Acquires 26,033 Shares of Becton, Dickinson and Company $BDX

Key Points

• BI Asset Management Fondsmaeglerselskab A S increased its stake in Becton, Dickinson and Company by 145.5% in the first quarter, buying 26,033 additional shares and lifting its total holdings to 43,927 shares worth about $6.9 million.
• Becton, Dickinson reported better-than-expected quarterly results, with EPS of $2.90 versus estimates of $2.77 and revenue of $4.71 billion, up 5.2% year over year. The company also guided FY2026 EPS to $12.52-$12.72.
• The company declared a quarterly dividend of $1.05 per share payable June 30, implying a 2.9% annualized yield. Meanwhile, insiders have been selling shares, and analysts currently rate the stock a consensus Hold with an average price target of $181.

BI Asset Management Fondsmaeglerselskab A S grew its holdings in Becton, Dickinson and Company (NYSE:BDX - Free Report) by 145.5% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 43,927 shares of the medical instruments supplier's stock after purchasing an additional 26,033 shares during the period. BI Asset Management Fondsmaeglerselskab A S's holdings in Becton, Dickinson and Company were worth $6,907,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Brighton Jones LLC increased its position in Becton, Dickinson and Company by 98.2% during the fourth quarter. Brighton Jones LLC now owns 1,770 shares of the medical instruments supplier's stock worth $401,000 after buying an additional 877 shares during the last quarter. Graybill Wealth Management LTD. boosted its stake in shares of Becton, Dickinson and Company by 47.3% during the 3rd quarter. Graybill Wealth Management LTD. now owns 27,592 shares of the medical instruments supplier's stock worth $5,164,000 after acquiring an additional 8,859 shares during the period. Skba Capital Management LLC boosted its stake in shares of Becton, Dickinson and Company by 1,619.9% during the 3rd quarter. Skba Capital Management LLC now owns 57,514 shares of the medical instruments supplier's stock worth $10,765,000 after acquiring an additional 54,170 shares during the period. Danske Bank A S acquired a new position in shares of Becton, Dickinson and Company during the 3rd quarter worth approximately $34,596,000. Finally, Elo Mutual Pension Insurance Co raised its stake in Becton, Dickinson and Company by 24.7% in the 3rd quarter. Elo Mutual Pension Insurance Co now owns 34,609 shares of the medical instruments supplier's stock valued at $6,478,000 after acquiring an additional 6,856 shares during the period. Institutional investors and hedge funds own 86.97% of the company's stock.

Becton, Dickinson and Company Stock Up 0.0%

BDX opened at $143.99 on Monday. The stock has a fifty day moving average of $148.89 and a 200-day moving average of $172.17. The company has a market capitalization of $39.67 billion, a P/E ratio of 36.45, a P/E/G ratio of 10.19 and a beta of 0.22. Becton, Dickinson and Company has a fifty-two week low of $127.59 and a fifty-two week high of $187.35. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.55 and a current ratio of 0.94.

Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The medical instruments supplier reported $2.90 EPS for the quarter, beating the consensus estimate of $2.77 by $0.13. Becton, Dickinson and Company had a net margin of 5.33% and a return on equity of 15.37%. The business had revenue of $4.71 billion for the quarter, compared to the consensus estimate of $4.67 billion. During the same period in the prior year, the company posted $3.35 earnings per share. Becton, Dickinson and Company's revenue was up 5.2% compared to the same quarter last year. Becton, Dickinson and Company has set its FY 2026 guidance at 12.520-12.720 EPS. On average, equities analysts expect that Becton, Dickinson and Company will post 12.61 EPS for the current year.

Becton, Dickinson and Company Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 9th will be given a dividend of $1.05 per share. This represents a $4.20 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date is Tuesday, June 9th. Becton, Dickinson and Company's dividend payout ratio is presently 106.33%.

Insider Activity at Becton, Dickinson and Company

In related news, EVP Michael David Garrison sold 1,100 shares of the stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $151.48, for a total transaction of $166,628.00. Following the sale, the executive vice president owned 14,272 shares of the company's stock, valued at $2,161,922.56. This represents a 7.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Thomas E. Polen, Jr. sold 2,764 shares of the firm's stock in a transaction on Monday, June 1st. The stock was sold at an average price of $146.35, for a total value of $404,511.40. Following the transaction, the chief executive officer owned 110,163 shares in the company, valued at approximately $16,122,355.05. This trade represents a 2.45% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 4,013 shares of company stock worth $593,434 over the last ninety days. Insiders own 0.40% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Argus reduced their price objective on shares of Becton, Dickinson and Company from $230.00 to $180.00 and set a "buy" rating for the company in a research report on Monday, March 23rd. Piper Sandler cut their target price on shares of Becton, Dickinson and Company from $170.00 to $159.00 and set a "neutral" rating for the company in a research note on Friday, April 17th. Barclays lifted their target price on shares of Becton, Dickinson and Company from $202.00 to $204.00 and gave the stock an "overweight" rating in a report on Monday, May 11th. Bank of America lowered their price target on shares of Becton, Dickinson and Company from $177.00 to $170.00 in a report on Friday, June 12th. Finally, Evercore raised their price objective on shares of Becton, Dickinson and Company from $180.00 to $190.00 in a research report on Thursday, May 7th. Seven analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $181.00.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company (BDX) is a global medical technology company that develops, manufactures and sells a broad range of medical devices, instrument systems and reagents. BD's products are used by healthcare institutions, clinical laboratories, life science researchers and the pharmaceutical industry to enable safe, effective delivery of care, specimen collection and diagnostic testing. The company's operations span multiple business areas focused on medical devices, life sciences research tools and interventional technologies.

BD's product portfolio includes single-use medical devices such as syringes, needles, needlesafety and injection systems, infusion therapy and medication management solutions, as well as vascular access, urology and oncology devices acquired through its interventional business.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.